Weed (BUDZ) Capital Expenditures (2010 - 2023)

Weed (BUDZ) recorded quarterly Capital Expenditures of $10000.0 in Q1 2023, down 96.26% quarter-over-quarter from $267499.0 in Q4 2021.

Weed (BUDZ) Capital Expenditures (2010 - 2023) Analysis & Trends

Weed's Capital Expenditures history runs 8 years deep, the most recent figure standing at $10000.0 for Q1 2023.

  • In Q1 2023, Capital Expenditures changed N/A year-over-year to $10000.0; the TTM figure through Dec 2023 stood at $10000.0 (changed N/A YoY), while the FY2023 annual figure was $10000.0, changed N/A from the prior year.
  • Capital Expenditures was $10000.0 for Q1 2023 at Weed, down from $267499.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $267499.0 in Q4 2021 to a low of -$163590.0 in Q3 2020.
  • Historically, Capital Expenditures has averaged $47368.7 across 4 years, with a median of $6867.0 in 2021.
  • The sharpest annual moves came in 2019 and 2021: Capital Expenditures slumped 99.13% in 2019, then soared 63.52% in 2021.
  • A 4-year view of Capital Expenditures shows it stood at $2979.0 in 2019, then jumped by 5391.44% to $163590.0 in 2020, then jumped by 63.52% to $267499.0 in 2021, then plunged by 96.26% to $10000.0 in 2023.
  • The last three Capital Expenditures figures came in at $10000.0 (Q1 2023), $267499.0 (Q4 2021), and $3734.0 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 168.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.09 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 8.83 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.04 Mn
10 Weed - - - -

Historic Data

Download Data
DateValue
Mar 31, 2023 10,000.00
Mar 31, 2023 10,000.00
Dec 31, 2021 267,499.00
Dec 31, 2021 267,499.00
Mar 31, 2021 3,734.00
Mar 31, 2021 3,734.00
Dec 31, 2020 163,590.00
Dec 31, 2020 163,590.00
Sep 30, 2020 -163,590.00
Sep 30, 2020 -163,590.00
Mar 31, 2019 2,979.00
Mar 31, 2019 2,979.00
Sep 30, 2018 475,761.00
Sep 30, 2018 475,761.00
Jun 30, 2018 10,067.00
Jun 30, 2018 10,067.00
Mar 31, 2018 340,653.00
Mar 31, 2018 340,653.00
Dec 31, 2017 24,755.00
Dec 31, 2017 24,755.00